Total net assets ($CAD):
$192.42 million

The top 15 holdings make up 68.28% of the Fund.
US Equity
International Equity
Cash and Equivalents
Canadian Equity
Other
United States
Japan
Germany
United Kingdom
Canada
France
Switzerland
Other
Brazil
Netherlands
Healthcare
Consumer Services
Financial Services
Cash and Cash Equivalent
Real Estate
Other
Top holdings Sector allocation (%)
Intercept Pharmaceuticals Inc Drugs 8.68%
Bristol-Myers Squibb Co Drugs 5.85%
Takeda Pharmaceutical Co Ltd Drugs 5.13%
SeaSpine Holdings Corp Diversified Healthcare 5.08%
CVS Health Corp Retail 5.01%
Biogen Idec Inc Drugs 5.01%
Astellas Pharma Inc Drugs 4.99%
Alexion Pharmaceuticals Inc Drugs 4.74%
Merit Medical Systems Inc Drugs 3.88%
Trupanion Inc Insurance 3.83%
GlaxoSmithKline PLC Drugs 3.66%
Fresenius Medical Care AG & Co KGaA Healthcare Services 3.49%
Ionis Pharmaceuticals Inc Drugs 3.30%
Forty Seven Inc Drugs 2.92%
Sanofi SA Drugs 2.71%
Asset allocation

US Equity 62.21%

International Equity 33.81%

Cash and Equivalents 2.37%

Canadian Equity 1.59%

Other 0.02%

Geographic allocation

United States 63.44%

Japan 12.62%

Germany 5.71%

United Kingdom 5.31%

Canada 2.73%

France 2.71%

Switzerland 2.19%

Other 1.94%

Brazil 1.87%

Netherlands 1.48%

Sector allocation

Healthcare 84.30%

Consumer Services 7.51%

Financial Services 3.83%

Cash and Cash Equivalent 2.37%

Real Estate 1.97%

Other 0.02%